- Home
- EXP vs RGC Comparison
EXP vs RGC Comparison
Compare EXP & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXP
- RGC
- Stock Information
- Founded
- EXP 1963
- RGC 2014
- Country
- EXP United States
- RGC Hong Kong
- Employees
- EXP N/A
- RGC N/A
- Industry
- EXP Building Materials
- RGC Medicinal Chemicals and Botanical Products
- Sector
- EXP Industrials
- RGC Health Care
- Exchange
- EXP Nasdaq
- RGC Nasdaq
- Market Cap
- EXP 7.4B
- RGC 8.4B
- IPO Year
- EXP 1994
- RGC 2021
- Fundamental
- Price
- EXP $208.43
- RGC $14.27
- Analyst Decision
- EXP Buy
- RGC
- Analyst Count
- EXP 9
- RGC 0
- Target Price
- EXP $252.22
- RGC N/A
- AVG Volume (30 Days)
- EXP 440.8K
- RGC 124.5K
- Earning Date
- EXP 10-30-2025
- RGC 10-24-2025
- Dividend Yield
- EXP 0.48%
- RGC N/A
- EPS Growth
- EXP N/A
- RGC N/A
- EPS
- EXP 13.52
- RGC N/A
- Revenue
- EXP $2,301,796,000.00
- RGC N/A
- Revenue This Year
- EXP $2.85
- RGC N/A
- Revenue Next Year
- EXP $4.52
- RGC N/A
- P/E Ratio
- EXP $15.41
- RGC N/A
- Revenue Growth
- EXP 1.50
- RGC N/A
- 52 Week Low
- EXP $191.91
- RGC $0.09
- 52 Week High
- EXP $321.93
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- EXP 34.31
- RGC 43.02
- Support Level
- EXP $203.42
- RGC $13.11
- Resistance Level
- EXP $210.10
- RGC $14.90
- Average True Range (ATR)
- EXP 5.90
- RGC 1.07
- MACD
- EXP -1.63
- RGC -0.13
- Stochastic Oscillator
- EXP 14.75
- RGC 32.68
About EXP Eagle Materials Inc
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.